🇺🇸 FDA
Patent

US 10143724

Anti-SSX-2 T cell receptors and related materials and methods of use

granted A61KA61K31/706A61K38/08

Quick answer

US patent 10143724 (Anti-SSX-2 T cell receptors and related materials and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/706, A61K38/08, A61K38/10, A61K38/177